Ideas to action: independent research for global prosperity
The Case for Globalization and Robust Global Value Chains
February 08, 2024
A New Vintage of Populism in Latin America
February 23, 2024
A New Playbook for Gavi: Advancing Equitable and Sustainable Immunization in an Evolving Global Landscape
January 30, 2024
For nearly 25 years, Gavi has delivered impact and value for money and remained one of the most successful global health initiatives. Gavi’s success has been driven by its use of three primary levers: (1) accelerating new vaccine introductions, (2) increasing equitable immunization coverage, and (3)...
A New Grand Bargain to Improve the Antimicrobial Market for Human Health
September 20, 2023
In our final working group report, we outline the principles of a Grand Bargain that we believe all stakeholders can and should sign up to during the UN General Assembly's High-Level Meeting on antimicrobial resistance in 2024. Explore our recommendations on increasing the availability of critically...
Overcoming Barriers to Improve Antimicrobial Access, Innovation, and Stewardship in India
July 31, 2023
India is racing against the clock in its fight against antimicrobial resistance. A combination of complex regulatory and procurement systems, a lack of health insurance penetration, and little groundwork on state and national action plans has stymied progress. A multifold approach is needed to impro...
Strategic Investment in Surveillance for Pandemic Preparedness: Rapid Review and Roundtable Discussion
June 20, 2023
This policy paper examines the state of knowledge on investing in the “best buys” of surveillance for pandemic preparedness. We conduct a rapid literature review to assess the state of knowledge on the costs and benefits of investing in four selected types of surveillance for respiratory infections,...
Leveraging Brazilian Leadership and Procurement Arrangements in the Fight Against Antimicrobial Resistance
June 08, 2023
Facing the high—and rising—burden of antimicrobial resistance (AMR), Brazil has an opportunity to improve access, stewardship, and innovation for critical antimicrobials at the national, regional, and/or global level(s) by modifying procurement arrangements. Brazil is positioned for significant dome...
Generating and Using Cost Evidence to Inform Provider Payment Rates: Lessons from High-Income Countries for India’s National Health Insurance Program
June 07, 2023
PM-JAY, India’s national health insurance program, is the largest publicly funded health insurance program in the world. It has reformed the way in which the poor and vulnerable access hospital care in India. The size of this program and the inclusion of private providers in delivering care has led ...
Facing the Pandemic of Antimicrobial Resistance: Current Actions and Future Challenges in Antibiotic Stewardship, Access, and Innovation in Brazil
May 18, 2023
Almost 140,000 people die with a drug-resistant bacterial infection in Brazil every year due in large part to shortcomings in access, stewardship, and innovation for antimicrobials. Brazil’s existing Productive Development Partnerships system could be modified to reduce incentives for overselling an...